Which pathway addresses chronic fatigue?
Fatigue is screened against sleep, thyroid, iron, B12, vitamin D, glucose, and mood. Confirmed deficits are repleted. Confirmed low testosterone routes to TRT; peri/menopausal patterns to BHRT; longevity-axis candidates to NAD+.
Full answer
Fatigue is the most common reason patients seek optimization care. The screen pairs sleep history (with apnea risk), TSH/free T4, ferritin and iron studies, B12, vitamin D, fasting glucose, HbA1c, hs-CRP, and mood. Confirmed deficits are repleted first because hormone optimization cannot substitute for reversible drivers. Men with confirmed low testosterone are evaluated for TRT. Peri/menopausal women are evaluated for BHRT. Patients prioritizing cellular and longevity-axis goals can add NAD+. Every plan is synchronous-video reviewed.
Educational. Not a substitute for individualized provider review.
- Testosterone Optimization pathway — Primary source · oMeds
- Reviewed by Dr. Laura Purdy, MD, MBA · Clinical Director, oMeds · Last reviewed 2026-06-03

